Presentation Information

[1P-741]Delivery of CRISPR-Cas9 by Lipid Nanoparticles (LNP) into Mouse Hematopoietic Stem Cells (HSC) to Cure Immunodeficiency

○Kayoko Shinozaki1,2, Toru Uchiyama3, Toru Yasuda3, Yuichiro Miyaoka1,2,4 (1. Reg. Med. Project, Tokyo Met. Inst. of Med. Sci., 2. Grad. Sch. of Tokyo Med. and Dent. Univ., 3. Div. of Molecular Pathogenesis, National Center for Child Health and Development, 4. Grad. Sch. of Hum. and Sci. Ochanomizu Univ.)

Password required to view


Comment

To browse or post comments, you must log in.Log in